Cargando…
Prescribers’ satisfaction with delivering medications for opioid use disorder
BACKGROUND: Expanding access to medications for opioid use disorder (MOUD), such as buprenorphine and extended release (XR) naltrexone, is critical to addressing the US opioid epidemic, but little is known about prescriber satisfaction with delivering these two types of MOUD. The current study descr...
Autores principales: | Knudsen, Hannah K., Brown, Randy, Jacobson, Nora, Horst, Julie, Kim, Jee-Seon, Kim, Hanna, Madden, Lynn M., Haram, Eric, Molfenter, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521499/ https://www.ncbi.nlm.nih.gov/pubmed/34663379 http://dx.doi.org/10.1186/s13011-021-00413-7 |
Ejemplares similares
-
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial
por: Molfenter, Todd, et al.
Publicado: (2017) -
Physicians’ satisfaction with providing buprenorphine treatment
por: Knudsen, Hannah K., et al.
Publicado: (2019) -
Opening the “black box” of organizational coaching for implementation
por: Fleddermann, Kathryn, et al.
Publicado: (2023) -
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
por: Molfenter, Todd, et al.
Publicado: (2018) -
The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015)